Physician profile
William Nassour
NPI 1104131820
$2,537.62
in general payments reported to CMS, 2019-2025
41 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $114 · 2021: $343 · 2022: $386 · 2023: $484 · 2024: $585 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $261.13 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ucb, INC. | $197.98 | 2024-2025 | Briviact, Nayzilam |
| Abbott Laboratories | $150.33 | 2022-2025 | Freestyle Libre 2, Octrode, Eterna |
| Lundbeck LLC | $122.22 | 2024-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $107.93 | 2024-2025 | Rexulti |
| Avanir Pharmaceuticals, INC. | $107.79 | 2019 | |
| Abiomed | $106.20 | 2021 | |
| Lucid Diagnostics INC. | $101.87 | 2021 | |
| Smith+Nephew, INC. | $100.77 | 2022-2024 | Grafix Pl, Renasys Touch |
| Novartis Pharmaceuticals Corporation | $99.98 | 2022-2024 | |
| Intuitive Surgical, INC. | $98.53 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $94.16 | 2021-2022 | |
| Ardelyx, INC. | $78.06 | 2024-2025 | Ibsrela |
| Scilex Pharmaceuticals INC. | $76.50 | 2023-2024 | Ztlido |
| Optos, INC. | $71.45 | 2020-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Nassour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.